The oxido-reductase activity of the apoptosis inducing factor: A promising pharmacological tool?

Current Pharmaceutical Design

Volumn 19, Issue 14, 2013, Pages 2628-2636

  Ferreira, Patricia ^a   Villanueva, Raquel ^a   Cabon, Lauriane ^b,c,d   Susín, Santos A ^b,c,d   Medina, Milagros ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Apoptosis inducing factor; Mitochondrial respiration; NADH reductase activity; Nucleus; Programmed cell death

Indexed keywords

APOPTOSIS INDUCING FACTOR; CYTOCHROME C OXIDASE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ARTICLE; CAENORHABDITIS ELEGANS; CELL DIFFERENTIATION; CELL SURVIVAL; CHROMATIN CONDENSATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DIMERIZATION; DNA DEGRADATION; DNA FRAGMENTATION; ELECTRON TRANSPORT; ENVIRONMENTAL STRESS; ENZYME ACTIVITY; GLUCOSE TRANSPORT; IN VITRO STUDY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NECROPTOSIS; NERVE DEGENERATION; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RETINA GANGLION CELL; RETINITIS PIGMENTOSA; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; DNA FRAGMENTATION; DRUG DISCOVERY; HUMANS; MITOCHONDRIA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; OXIDOREDUCTASES; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

EID: 84877814906     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319140012     Document Type: Article

References (92)

1. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004; 116: 205-19.
2. Zornig M, Hueber A, Baum W, Evan G. Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta 2001; 1551: F1-37.
3. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-12.
4. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004; 16: 663-9.
5. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
6. Lorenzo HK, Susin SA. Mitochondrial effectors in caspaseindependent cell death. FEBS Lett 2004; 557: 14-20.
7. Jaattela M, Tschopp J. Caspase-independent cell death in T lymphocytes. Nat Immunol 2003; 4: 416-23.
8. Jaattela M. Programmed cell death: many ways for cells to die decently. Ann Med 2002; 34: 480-8.
9. Natarajan SK, Becker DF. Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress. Cell Health Cytoskelet 2012; 2012: 11-27.
10. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-6.
11. Lorenzo HK, Susin SA, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 1999; 6: 516-24.
12. Flynn AN, Wang A, McKay DM, Buret AG. Apoptosis-inducing factor contributes to epithelial cell apoptosis induced by enteropathogenic Escherichia coli. Can J Physiol Pharmacol 2011; 89: 143-8.
13. Miramar MD, Costantini P, Ravagnan L, et al. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 2001; 276: 16391-8.
14. Sevrioukova IF. Apoptosis-inducing factor: structure, function, and redox regulation. Antioxid Redox Signal 2011; 14: 2545-79.
15. Mate MJ, Ortiz-Lombardia M, Boitel B, et al. The crystal structure of the mouse apoptosis-inducing factor AIF. Nat Struct Biol 2002; 9: 442-6.
16. Vahsen N, Cande C, Briere JJ, et al. AIF deficiency compromises oxidative phosphorylation. Embo J 2004; 23: 4679-89.
17. Sevrioukova IF, Li H, Poulos TL. Crystal structure of putidaredoxin reductase from Pseudomonas putida, the final structural component of the cytochrome P450cam monooxygenase. J Mol Biol 2004; 336: 889-902.
18. Sevrioukova IF. Redox-linked conformational dynamics in apoptosis-inducing factor. J Mol Biol 2009; 390: 924-38.
19. Churbanova IY, Sevrioukova IF. Redox-dependent changes in molecular properties of mitochondrial apoptosis-inducing factor. J Biol Chem 2008; 283: 5622-31.
20. Cande C, Cecconi F, Dessen P, Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci 2002; 115: 4727-34.
21. Daugas E, Nochy D, Ravagnan L, et al. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 2000; 476: 118-23.
22. Ye H, Cande C, Stephanou NC, et al. DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol 2002; 9: 680-4.
23. Lipton SA, Bossy-Wetzel E. Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell 2002; 111: 147-50.
24. Otera H, Ohsakaya S, Nagaura Z, Ishihara N, Mihara K. Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space. Embo J 2005; 24: 1375-86.
25. Polster BM, Basanez G, Etxebarria A, Hardwick JM, Nicholls DG. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem 2005; 280: 6447-54.
26. Gurbuxani S, Schmitt E, Cande C, et al. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene 2003; 22: 6669-78.
27. Zhu C, Wang X, Deinum J, et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med 2007; 204: 1741-8.
28. Hangen E, De Zio D, Bordi M, et al. A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2. Cell Death Differ 2010; 17: 1155-66.
29. Loeffler M, Daugas E, Susin SA, et al. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. Faseb J 2001; 15: 758-67.
30. Delettre C, Yuste VJ, Moubarak RS, et al. AIFsh, a novel apoptosis-inducing factor (AIF) pro-apoptotic isoform with potential pathological relevance in human cancer. J Biol Chem 2006; 281: 6413-27.
31. Delettre C, Yuste VJ, Moubarak RS, et al. Identification and characterization of AIFsh2, a mitochondrial apoptosis-inducing factor (AIF) isoform with NADH oxidase activity. J Biol Chem 2006; 281: 18507-18.
32. Artus C, Boujrad H, Bouharrour A, et al. AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. Embo J 2010; 29: 1585-99.
33. Susin SA, Zamzami N, Castedo M, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996; 184: 1331-41.
34. Susin SA, Zamzami N, Larochette N, et al. A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: application to ceramide-induced apoptosis. Exp Cell Res 1997; 236: 397-403.
35. Zamzami N, Susin SA, Marchetti P, et al. Mitochondrial control of nuclear apoptosis. J Exp Med 1996; 183: 1533-44.
36. Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004; 4: 592-603.
37. Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 2003; 40: 401-13.
38. Melino G, Knight RA, Nicotera P. How many ways to die? How many different models of cell death? Cell Death Differ 2005; 12 Suppl 2: 1457-62.
39. Cande C, Vahsen N, Kouranti I, et al. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 2004; 23: 1514-21.
40. Wang X, Yang C, Chai J, Shi Y, Xue D. Mechanisms of AIFmediated apoptotic DNA degradation in Caenorhabditis elegans. Science 2002; 298: 1587-92.
41. Niikura Y, Dixit A, Scott R, Perkins G, Kitagawa K. BUB1 mediation of caspase-independent mitotic death determines cell fate. J Cell Biol 2007; 178: 283-96.
42. Kitagawa K, Niikura Y. Caspase-independent mitotic death (CIMD). Cell Cycle 2008; 7: 1001-5.
43. Baritaud M, Boujrad H, Lorenzo HK, Krantic S, Susin SA. Histone H2AX: The missing link in AIF-mediated caspase-independent programmed necrosis. Cell Cycle; 9: 3166-73.
44. Vahsen N, Cande C, Dupaigne P, et al. Physical interaction of apoptosis-inducing factor with DNA and RNA. Oncogene 2006; 25: 1763-74.
45. Joza N, Oudit GY, Brown D, et al. Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol 2005; 25: 10261-72.
46. Cheung EC, Joza N, Steenaart NA, et al. Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. Embo J 2006; 25: 4061-73.
47. Feraud O, Debili N, Penninger JM, Kroemer G. Cavitation of embryoid bodies requires optimal oxidative phosphorylation and AIF. Cell Death Differ 2007; 14: 385-7.
48. Klein JA, Longo-Guess CM, Rossmann MP, et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 2002; 419: 367-74.
49. Pospisilik JA, Knauf C, Joza N, et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 2007; 131: 476-91.
50. Benit P, Goncalves S, Dassa EP, Briere JJ, Rustin P. The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes. PLoS One 2008; 3: e3208.
51. Schulthess FT, Katz S, Ardestani A, et al. Deletion of the mitochondrial flavoprotein apoptosis inducing factor (AIF) induces beta-cell apoptosis and impairs beta-cell mass. PLoS One 2009; 4: e4394.
52. Chinta SJ, Rane A, Yadava N, et al. Reactive oxygen species regulation by AIF-and complex I-depleted brain mitochondria. Free Radic Biol Med 2009; 46: 939-47.
53. Akematsu T, Endoh H. Role of apoptosis-inducing factor (AIF) in programmed nuclear death during conjugation in Tetrahymena thermophila. BMC Cell Biol 2010; 11: 13.
54. Joza N, Galindo K, Pospisilik JA, et al. The molecular archaeology of a mitochondrial death effector: AIF in Drosophila. Cell Death Differ 2008; 15: 1009-18.
55. Ishimura R, Martin GR, Ackerman SL. Loss of apoptosis-inducing factor results in cell-type-specific neurogenesis defects. J Neurosci 2008; 28: 4938-48.
56. van Empel VP, Bertrand AT, van der Nagel R, et al. Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res 2005; 96: e92-e101.
57. Yu W, Mechawar N, Krantic S, Quirion R. Evidence for the involvement of apoptosis-inducing factor-mediated caspaseindependent neuronal death in Alzheimer disease. Am J Pathol 2010; 176: 2209-18.
58. Galluzzi L, Morselli E, Kepp O, Kroemer G. Targeting postmitochondrial effectors of apoptosis for neuroprotection. Biochim Biophys Acta 2009; 1787: 402-13.
59. Culmsee C, Zhu C, Landshamer S, et al. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 2005; 25: 10262-72.
60. Hisatomi T, Nakazawa T, Noda K, et al. HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice. J Clin Invest 2008; 118: 2025-38.
61. Wang H, Yu SW, Koh DW, et al. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci 2004; 24: 10963-73.
62. Zanna C, Ghelli A, Porcelli AM, et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008; 131: 352-67.
63. Olichon A, Guillou E, Delettre C, et al. Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta 2006; 1763: 500-9.
64. John GB, Shang Y, Li L, et al. The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol Biol Cell 2005; 16: 1543-54.
65. Karbowski M, Youle RJ. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ 2003; 10: 870-80.
66. Paumard P, Vaillier J, Coulary B, et al. The ATP synthase is involved in generating mitochondrial cristae morphology. Embo J 2002; 21: 221-30.
67. Cande C, Vahsen N, Metivier D, et al. Regulation of cytoplasmic stress granules by apoptosis-inducing factor. J Cell Sci 2004; 117: 4461-8.
68. Schmitt E, Parcellier A, Gurbuxani S, et al. Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosisinducing factor mutant. Cancer Res 2003; 63: 8233-40.
69. Ghezzi D, Sevrioukova I, Invernizzi F, et al. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. Am J Hum Genet 2010; 86: 639-49.
70. Wang Y, Kim NS, Haince JF, et al. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci Signal 2011; 4: ra20.
71. Shumway SD, Maki M, Miyamoto S. The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. J Biol Chem 1999; 274: 30874-81.
72. Matsumori Y, Hong SM, Aoyama K, et al. Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J Cereb Blood Flow Metab 2005; 25: 899-910.
73. Ravagnan L, Gurbuxani S, Susin SA, et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 2001; 3: 839-43.
74. Lewis EM, Wilkinson AS, Davis NY, Horita DA, Wilkinson JC. Nondegradative Ubiquitination of Apoptosis Inducing Factor (AIF) by X-Linked Inhibitor of Apoptosis at a Residue Critical for AIFMediated Chromatin Degradation. Biochemistry 2011; 50: 11084-96.
75. Lim MJ, Min SH, Lee JJ, et al. Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors. Mol Ther 2006; 13: 899-909.
76. Collingwood TS, Smirnova EV, Bogush M, et al. T-cell ubiquitin ligand affects cell death through a functional interaction with apoptosis-inducing factor, a key factor of caspase-independent apoptosis. J Biol Chem 2007; 282: 30920-8.
77. Zhang Y, Han T, Zhu Q, et al. The proapoptotic activity of Cterminal domain of apoptosis-inducing factor (AIF) is separated from its N-terminal. Biol Res 2009; 42: 249-60.
78. Lorenzo HK, Susin SA. Therapeutic potential of AIF-mediated caspase-independent programmed cell death. Drug Resist Updat 2007; 10: 235-55.
79. Rugo H, Shtivelman E, Perez A, et al. Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat 2007; 105: 17-28.
80. Wang M, Han XH, Zhang L, et al. Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo. Leukemia 2008; 22: 179-85.
81. Wang M, Zhang L, Han X, et al. Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways. Blood 2007; 109: 5455-62.
82. Maddika S, Ande SR, Panigrahi S, et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 2007; 10: 13-29.
83. Cuerrier D, Moldoveanu T, Inoue J, Davies PL, Campbell RL. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography. Biochemistry 2006; 45: 7446-52.
84. Delavallee L, Cabon L, Galan-Malo P, Lorenzo HK, Susin SA. AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life 2012; 63: 221-32.
85. Schmitt E, Maingret L, Puig PE, et al. Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma. Cancer Res 2006; 66: 4191-7.
86. Suemasu S, Tanaka K, Namba T, et al. A role for HSP70 in protecting against indomethacin-induced gastric lesions. J Biol Chem 2009; 284: 19705-15.
87. Choudhury S, Bae S, Ke Q, et al. Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion. Basic Res Cardiol 2011; 106: 397-407.
88. Millan A, Huerta S. Apoptosis-inducing factor and colon cancer. J Surg Res 2009; 151: 163-70.
89. Yu CJ, Jia LT, Meng YL, et al. Selective proapoptotic activity of a secreted recombinant antibody/AIF fusion protein in carcinomas overexpressing HER2. Gene Ther 2006; 13: 313-20.
90. Chan LL, Pineda M, Heeres JT, Hergenrother PJ, Cunningham BT. A general method for discovering inhibitors of protein-DNA interactions using photonic crystal biosensors. ACS Chem Biol 2008; 3: 437-48.
91. Bouaita A, Augustin S, Lechauve C, et al. Downregulation of apoptosis-inducing factor in Harlequin mice induces progressive and severe optic atrophy which is durably prevented by AAV2-AIF1 gene therapy. Brain 2012; 135: 35-52.
92. Urbano A, Lakshmanan U, Choo PH, et al. AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells. Embo J 2005; 24: 2815-26.